HMPL 653
Alternative Names: HMPL-653Latest Information Update: 28 Feb 2025
At a glance
- Originator HUTCHMED
- Class Antineoplastics; Small molecules
- Mechanism of Action Macrophage colony-stimulating factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Giant cell tumour of tendon sheath; Solid tumours
Most Recent Events
- 28 Feb 2025 No recent reports of development identified for phase-I development in Giant-cell-tumour-of-tendon-sheath in China (PO)
- 28 Feb 2025 No recent reports of development identified for phase-I development in Solid-tumours(Late-stage disease, Metastatic disease) in China (PO)
- 11 Oct 2023 Pharmacodynamics data from a preclinical trial in Solid tumours presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC-2023)